ORIN1001 in Patients With Advanced Solid Tumors and Relapsed Refractory Metastatic Breast Cancer
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Advanced Solid Tumor|Metastatic Breast Cancer
Interventions: DRUG: Abraxane
Sponsor: Orinove, Inc.